A carregar...
Cisplatin influences acquisition of resistance to molecular‐targeted agents through epithelial–mesenchymal transition‐like changes
Chemotherapy with platinum agents is the standard of care for non‐small‐cell lung cancer (NSCLC); however, novel molecular‐targeted agents like gefitinib have been approved for advanced NSCLCs, including recurrent cases previously treated with platinum‐based chemotherapy. Although these agents show...
Na minha lista:
| Publicado no: | Cancer Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2013
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7657214/ https://ncbi.nlm.nih.gov/pubmed/23566288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12171 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|